Advertisement

Journal of Molecular Modeling

, Volume 15, Issue 12, pp 1447–1462 | Cite as

An ab initio quantum mechanical drug designing procedure: application to the design of balanced dual ACE/NEP inhibitors

  • Nishi K. Rao
  • Arpita YadavEmail author
  • Sanjeev Kumar Singh
Original Paper

Abstract

This article describes in a sequential fashion how ab initio quantum mechanical methods can be applied to study the pharmacophoric features of drugs. It also describes how accurate drug–receptor interaction calculations can guide the careful design of balanced dual inhibitors, which form an important class of second generation drugs. As an example, the authors have chosen balanced inhibitors of angiotensin converting enzyme/neutral endopeptidase (ACE/NEP) as modern antihypertensive drugs. A unified, accurate, in silico design approach is presented, encompassing all steps from pharmacophore derivation to complete understanding of mechanistic aspects leading to drug design.

Figure

Lisinopril docked in angiotensin converting enzyme (ACE) model

Keywords

Ab initio Drug–receptor interaction ACE/NEP dual inhibitor ACE receptor model Modern antihypertensive 

Notes

Acknowledgments

We gratefully acknowledge financial support by DST (Department of Science and Technology, New Delhi) project no. SR/S1/PC-06/2004. One of us (N. K. Rao) gratefully acknowledges DST for the Senior Research Fellowship.

Supplementary material

894_2009_500_MOESM1_ESM.doc (259 kb)
Suppl. 1 Different optimised conformations of Enalaprilat (DOC 259 kb)
894_2009_500_MOESM2_ESM.doc (614 kb)
Suppl. 2 Bioactive Enalaprilat docked in ACE active site model (best orientation) (DOC 614 kb)
894_2009_500_MOESM3_ESM.doc (394 kb)
Suppl. 3 Bioactive Enalaprilat docked in ACE active site model (different orientation) (DOC 394 kb)
894_2009_500_MOESM4_ESM.doc (25 kb)
Suppl. 4 (DOC 25 kb)
Suppl. 5

(WMV 1536 kb)

References

  1. 1.
    Patrick G (ed) (2002) In: Medicinal Chemistry. BIOS Scientific, Oxford, pp 221–241Google Scholar
  2. 2.
    Cushman DW, Ondetti MA (1999) Nat Med 5:1110–1113CrossRefGoogle Scholar
  3. 3.
    Ondetti MA (1994) Annu Rev Pharmacol Toxicol 34:1–16Google Scholar
  4. 4.
    Gupta SP (ed) (2006) QSAR and molecular modeling studies in heterocyclic drugs II. Springer, BerlinGoogle Scholar
  5. 5.
    Crippen GM (2008) Curr Comp Aided Drug Des 4:259–264CrossRefGoogle Scholar
  6. 6.
    Zhou P, Tian F, Wu Y, Li Z, Shang Z (2008) Curr Comp Aided Drug Des 4:311–321CrossRefGoogle Scholar
  7. 7.
    Meng EC, Shoichet BK, Kuntz ID (1992) J Comp Chem 13:505–524CrossRefGoogle Scholar
  8. 8.
    Breda A, Basso LA, Santos DS, de Azevedo Jr WF (2008) Curr Comp Aided Drug Des 4:265–272CrossRefGoogle Scholar
  9. 9.
    Dalton JA, Jackson RM (2007) Bioinformatics 23:1901–1908CrossRefGoogle Scholar
  10. 10.
    Waszkowycz B, Perkins TDJ, Sykes RA, Li J (2001) IBM Syst J 40:360–378Google Scholar
  11. 11.
    Zhorov BS (1997) Arch Biochem Biophys 341:238–244CrossRefGoogle Scholar
  12. 12.
    Yadav A, Singh SK (2005) THEOCHEM 723:205–209CrossRefGoogle Scholar
  13. 13.
    Jain S, Yadav A (2008) Chem Biol Drug Des 71:271–277CrossRefGoogle Scholar
  14. 14.
    Jandeleit-Dahm K (2006) J Hum Hypertens 20:478–481CrossRefGoogle Scholar
  15. 15.
    Opie LH (1992) Angiotensin converting enzyme inhibitors. Wiley-Lisa, New YorkGoogle Scholar
  16. 16.
    Edwards C (1985) Lancet 325:30–34CrossRefGoogle Scholar
  17. 17.
    Jackson B, Cubela RB, Conway EL, Johnston CI (1988) J Clin Pharmacol 25:719–724Google Scholar
  18. 18.
    Acharya KR, Sturrock ED, Riordan JF, Ehlers MRW (2003) Nat Rev Drug Disc 2:891–902CrossRefGoogle Scholar
  19. 19.
    Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, Adam A (2002) J Pharmacol Exp Ther 303:232–237CrossRefGoogle Scholar
  20. 20.
    Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA (1989) Am J Med 87:24S–28SCrossRefGoogle Scholar
  21. 21.
    Wei L, Clauser E, Alhenc Gelas F, Corvol P (1992) J Biol Chem 267:13398–13405Google Scholar
  22. 22.
    Ehler MR, Riordan JF (1991) Biochemistry 30:7118–7126CrossRefGoogle Scholar
  23. 23.
    Georgiadis D, Beau F, Czarny B, Cotton I, Yiotakis A, Dive V (2003) Circ Res 93:148–154CrossRefGoogle Scholar
  24. 24.
    Dive V, Cotton J, Yiotakis A, Michaud A, Vassiliou S, Jiracek J, Vazeux G, Chauvet MT, Cuniasse P, Corvol P (1999) Proc Natl Acad Sci USA 96:4330–4335CrossRefGoogle Scholar
  25. 25.
    Georgiadis D, Cuniasse P, Cotton J, Yiotakis A, Dive V (2004) Biochemistry 43:8048–8054CrossRefGoogle Scholar
  26. 26.
    Laurent S, Boutouyrie P, Azizi M, Marie C, Gros C, Schwartz JC, Lecomte JM, Bralet J (2000) Hypertension 35:1148–1153Google Scholar
  27. 27.
    Weber M (1999) Am J Hypertens 12:139S–147SCrossRefGoogle Scholar
  28. 28.
    Leung D, Abbenante G, Fairlie DP (2000) J Med Chem 43:305–341CrossRefGoogle Scholar
  29. 29.
    Chevillard C, Jouquey S, Bree F, Mathieu M N, Stepniewski J P, Tillement JP, Hamon G, Corvol PJ (1994) Cardiovasc Pharmacol 4[suppl 23]:S1L–SL5Google Scholar
  30. 30.
    Oefner C, Roques BP, Fournie-Zaluski MC, Dale GE (2004) Acta Crystallogr D 60:392–396CrossRefGoogle Scholar
  31. 31.
    Marie-Claire C, Ruffet E, Antonczak S, Beaumont A, Donohue MO, Fournie-Zaluski MC (1997) J Biochem 36:13938–13945CrossRefGoogle Scholar
  32. 32.
    Barthelmebs M, Devissaquet M, Imbs JL (1989) Clin Exp Hypertens A11 [Suppl 2]:471–486Google Scholar
  33. 33.
    Sagnella GA (2002) J Renin Angiotensin Aldosterone Syst 3:90–95CrossRefGoogle Scholar
  34. 34.
    Bralet J, Schwartz JC (2001) Trends Pharmacol Sci 22:106–109CrossRefGoogle Scholar
  35. 35.
    Molineux G, Rouleau J, Adam A (2002) Curr Opin Pharmacol 2:131–141CrossRefGoogle Scholar
  36. 36.
    Peng C, Ayala PY, Schlegel HB, Frisch MJ (1996) J Comput Chem 17:49–56CrossRefGoogle Scholar
  37. 37.
    Peng C, Schlegel HB (1994) Israel J Chem 33:449Google Scholar
  38. 38.
    Petersson GA, Al-Laham MA (1991) J Chem Phys 94:6081–6090CrossRefGoogle Scholar
  39. 39.
    Petersson GA, Bennett A, Tensfeldt TG, Al-Laham MA, Shirley WA, Mantzaris J (1988) J Chem Phys 89:2193–2218CrossRefGoogle Scholar
  40. 40.
    Becke AD (1993) J Chem Phys 98:5648–5652CrossRefGoogle Scholar
  41. 41.
    Breneman CM, Wiberg KB (1990) J Comput Chem 11:361–373CrossRefGoogle Scholar
  42. 42.
    Schrodinger (2008) PHASE, Version 3.0. LLC, New York, NYGoogle Scholar
  43. 43.
    Dixon SL, Smondyrev AM, Rao SN (2006) Chem Biol Drug Des 67:370–372CrossRefGoogle Scholar
  44. 44.
    Peitsch MC, Guex N (1997) Electrophoresis 18:2714–2723CrossRefGoogle Scholar
  45. 45.
    Dennington R II, Keith T, Millam J, Eppinnett K, Hovell WL, Gilliland R (2003) GaussView, Version 3.09. Semichem, Shawnee Mission, KSGoogle Scholar
  46. 46.
    Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2004) Gaussian 03, Revision C.02. Gaussian, Wallingford CTGoogle Scholar
  47. 47.
    Hehre WJ, Ditchfield R, Pople JA (1972) J Chem Phys 56:2257–2261CrossRefGoogle Scholar
  48. 48.
    Schlegel HB (1989) In: Bertran J (ed) New theoretical concepts for understanding organic reactions. Kluwer Academic, Dordrecht, pp 33–53Google Scholar
  49. 49.
    Natesh R, Schwager SLU, Evans HR, Sturrock ED, Acharya KR (2004) Biochemistry 43:8718–8724CrossRefGoogle Scholar
  50. 50.
    Oefner C, Roques BP, Fournie-Zaluski MC, Dale GE (2004) Acta Crystallogr D 60:392–396CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Nishi K. Rao
    • 1
  • Arpita Yadav
    • 1
    Email author
  • Sanjeev Kumar Singh
    • 2
  1. 1.Department of Chemistry, University Institute of Engineering and Technology CSJM UniversityKanpurIndia
  2. 2.Centre of Excellence in Bioinformatics, Department of Genetic Engineering, School of BiotechnologyMadurai Kamaraj UniversityMaduraiIndia

Personalised recommendations